A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma | |
Feng, Jifeng; Wu, Jianqiu; Song, Yongping; Su, Liping; Zhang, Mingzhi; Li, Wei; Hu, Yu; Zhang, Xiaohong; Gao, Yuhuan; Feng, Ru | |
刊名 | BLOOD |
2014 | |
卷号 | 124期号:21 |
ISSN号 | 0006-4971 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3440624 |
专题 | 昆明医科大学 |
推荐引用方式 GB/T 7714 | Feng, Jifeng,Wu, Jianqiu,Song, Yongping,et al. A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma[J]. BLOOD,2014,124(21). |
APA | Feng, Jifeng.,Wu, Jianqiu.,Song, Yongping.,Su, Liping.,Zhang, Mingzhi.,...&Cui, Tongjian.(2014).A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma.BLOOD,124(21). |
MLA | Feng, Jifeng,et al."A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma".BLOOD 124.21(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论